C$ R Q B U$ R V V Q F 1 I T

Transcription

1 INNOVATION. SCIENCE. OPPORTUNITY. C$ R Q B U$ R V V Q F 1 I T

2 F O R W A R D L O O K I N G S T A T E M E N T This presentation contains forward-looking statements. These forward-looking statements are not based on historical facts but rather on company expectations regarding future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, Business prospects and opportunities. Statements in this presentation about future plans and intentions, results, level of activity, performance, goals or achievements or other future events constitute forward-looking statements. Wherever possible, words such as anticipate:, believe, expect, may, could, will, forecast, potential, intend, estimate, should, plan, predict, or the negative or other variations of statements reflects managements current beliefs and assumptions and are based on information currently available to the Company management. Certain risk factors may cause actual results, level of activity, performance or achievements to differ materially from those implied by forward-looking statements. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this presentation are based upon what the Company management believes to be reasonable assumptions, investors cannot be assured that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this presentation and the Company assumes no obligation to update or revise them to reflect new events or circumstances. 2

3 F O U R P I L L A R S A P P R O A C H Services Division Immediate Revenue Cash Flow Positive Deal flow for Investment Division Investment Division 51,000 kg / yr at buildout Expansion pipeline is full Indigenous Peoples Partnerships Scientific Leadership R&D Initiatives Partnered with McGill University

4 P I L L A R O N E : S E R V I C E S D I V I S I O N The genesis of RavenQuest came from a small team of dedicated professionals whose depth of knowledge is unsurpassed in Canada Comprehensive, integrated solutions to companies in the regulated cannabis market in Canada Proprietary, automated systems for growing, drying, monitoring designed specifically for cannabis yield maximization Unmatched industry best practices and experience Exceptional Knowledge = Exceptional Product

5 S E R V I C E S D I V I S I O N : U N F A I R A D V A N T A G E C A N N A B I S 2. 0 Orbital Garden 2.0 or OG 2.0 Fully automated 64 sf 500 sf Unrivaled control of the plant s environment for repeatable, consistent product Yields from OG 2.0 more than double flat table facilities Superior yields will fight margin pressure as the industry matures

6 P I L L A R T W O : I N V E S T M E N T D I V I S I O N F U N D E D C A P A C I T Y V S. B U I L T C A P A C I T Y! Markham, Ontario Licensed Producer 2,200 kg current production 4,000 kg capacity with Orbital Garden grow technology

7 I N V E S T M E N T D I V I S I O N : F A C I L I T I E S Edmonton, Alberta Edmonton facility near completion 7,000 kg capacity Additional land to expand the facility to more than double capacity as a second stage

8 I N V E S T M E N T D I V I S I O N : F A C I L I T I E S Western Agripharma Limited: Port Mellon, British Columbia (Sunshine Coast) (LOI) 125,000 square foot facility, purpose built, 100% interest Procuring financing of facility via bank and sub debt 25,000 kg capacity

9 I N V E S T M E N T D I V I S I O N : F A C I L I T I E S Fort McMurray #468 First Nation: Fort McMurray, Alberta 250,000 square foot facility, purpose built, 30% interest Procuring financing of facility via bank and sub debt 50,000 kg capacity

10 I N V E S T M E N T D I V I S I O N : R E C R E A T I O N A L B R A N D R O L L O U T Supply MOU with BCLDB Brand rollout timed for one week prior to legalization October 17 Brand focus is environmental sustainability, consistent and repeatable experiences for patients and consumers Foundation based in science-based grow methodologies, connection to and understanding of the plant

11 P I L L A R T H R E E : I N D I G E N O U S P E O P L E S P A R T N E R S H I P S Bill Robinson leads Government/ Indigenous Relations and Strategic Partnerships 34 years with RCMP, retired as commanding officer D Division Former President and CEO, Alberta Gaming & Liquor Commission (AGLC) - Alberta Gaming and Liquor Commission will serve as the central wholesaler for all cannabis product sold in Alberta Extensive relationships with Indigenous Peoples across Canada Favorable taxation regime for facility construction, cannabis production & sale on sovereign Indigenous lands Healthy pipeline of engagements with Indigenous Peoples Agreements with Fort McMurray & Alexander First Nations

12 P I L L A R F O U R : M C G I L L R & D P A R T N E R S H I P Landmark research partnership with McGill University Development of top level plant science aimed at yield maximization disease resistance Stabilize the cannabis plant for consistency and repeatability of the experience for consumers and patients Dr. Donald Smith - patented technologies for improvement of crop yields Dr. Mark Ware - medical cannabis researcher; Director of clinical research at the Allen Edwards Pain Management Unit at the McGill University Health Center (MUHC)

13 R Q B S T W O D I S T I N C T D I V I S I O N S W O R K T O G E T H E R SERVICES DIVISION: ESTABLISHED Key adviser to extensive and reputable list of clients End-to-end solution provider for existing LPs and late-stage applicants Facility design, construction Proprietary, industry-leading growing and drying technologies INVESTMENT DIVISION Western Agripharma 125,000 sq foot facility planned:25,000 kg year FM ,000 sq foot facility planned: 15,000 kg/year Bloomera 20,000 sq foot Licensed facility: 4,000 kg/year AGB 35,500 sq foot, 7,000 kg/year production facility completed mid ,000 kg/year funded production by late 2018 Strategically positioned for expansion due to consultancy relationships Focus on partnerships with Indigenous Peoples

14 F O U R P I L L A R S A P P R O A C H Services Division Immediate Revenue Cannabis 2.0 technology Deal flow for Investment Division Investment Division 51,000 kg / yr at buildout Expansion pipeline is full Indigenous Peoples Partnerships Scientific Leadership R&D Initiatives Partnered with McGill University

15 Shares Issued and Outstanding Share Price (March 2018) Market Capitalization 105,918,053 C$0.78 ~ C$83 Million

16 T H A N K Y O U George Robinson CEO Ravenquest BioMed Inc. Suite West Hastings Street, Vancouver BC, Canada, V6E 2K mathieu.mcdonald@rqbglobal.com